Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BIOC
2001
DELISTED
Biocept, Inc.
BIOC
| $2.7M | ﹤0.01% |
12,655
+6,574
| +108% | +$943K |
|
2002
Navigator Holdings
NVGS
$1.29B
| $2.69M | ﹤0.01% |
419,100
-206,508
| -33% | -$1.29M |
|
2003
TTM Technologies
TTMI
$14.7B
| $2.69M | ﹤0.01% |
+227,269
| New | +$2.53M |
|
2004
iShares Russell 1000 Value ETF
IWD
$84.2B
| $2.68M | ﹤0.01% |
+23,800
| New | +$2.62M |
|
2005
Larimar Therapeutics
LRMR
$453M
| $2.68M | ﹤0.01% |
208,574
+28,528
| +16% | +$332K |
|
|
EGIO
2006
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.68M | ﹤0.01% |
9,102
+7,695
| +547% | +$1.71M |
|
2007
LGL Group
LGL
$93.6M
| $2.67M | ﹤0.01% |
832,447
+76,142
| +10% | +$246K |
|
2008
Curis
CRIS
$3.76M
| $2.67M | ﹤0.01% |
5,510
+1,479
| +37% | +$545K |
|
|
STEL
2009
DELISTED
Stellar Bancorp
STEL
| $2.67M | ﹤0.01% |
126,910
+11,700
| +10% | +$217K |
|
2010
InterContinental Hotels
IHG
$23.6B
| $2.66M | ﹤0.01% |
59,983
-112,774
| -65% | -$5.1M |
|
2011
Kforce
KFRC
$1.04B
| $2.65M | ﹤0.01% |
90,649
+77,249
| +576% | +$2.25M |
|
|
AIOT
2012
PowerFleet Inc
AIOT
$417M
| $2.65M | ﹤0.01% |
573,249
+88,020
| +18% | +$409K |
|
2013
ICF International
ICFI
$1.59B
| $2.64M | ﹤0.01% |
+40,700
| New | +$2.67M |
|
2014
Vulcan Materials
VMC
$36.5B
| $2.64M | ﹤0.01% |
+22,765
| New | +$2.49M |
|
2015
Comp X International
CIX
$385M
| $2.63M | ﹤0.01% |
190,646
+2,846
| +2% | +$40.6K |
|
|
TGH
2016
DELISTED
Textainer Group Holdings limited
TGH
| $2.63M | ﹤0.01% |
321,000
-263,300
| -45% | -$2.16M |
|
2017
MSC Industrial Direct
MSM
$6.91B
| $2.62M | ﹤0.01% |
36,000
+28,100
| +356% | +$1.81M |
|
|
PFBI
2018
DELISTED
Premier Financial Bancorp
PFBI
| $2.62M | ﹤0.01% |
204,187
-48,101
| -19% | -$596K |
|
|
CDR
2019
DELISTED
Cedar Realty Trust, Inc
CDR
| $2.62M | ﹤0.01% |
400,483
-57,322
| -13% | -$352K |
|
2020
ePlus
PLUS
$2.31B
| $2.62M | ﹤0.01% |
74,000
+55,600
| +302% | +$1.9M |
|
|
HA
2021
DELISTED
Hawaiian Holdings, Inc.
HA
| $2.61M | ﹤0.01% |
186,200
+23,100
| +14% | +$315K |
|
|
MANT
2022
DELISTED
Mantech International Corp
MANT
| $2.61M | ﹤0.01% |
38,100
+7,600
| +25% | +$559K |
|
|
TBI
2023
Trueblue
TBI
$311M
| $2.6M | ﹤0.01% |
170,600
+130,900
| +330% | +$1.94M |
|
2024
Kadant
KAI
$3.95B
| $2.6M | ﹤0.01% |
26,100
-4,700
| -15% | -$418K |
|
|
PMD
2025
DELISTED
Psychemedics Corporation
PMD
| $2.6M | ﹤0.01% |
468,454
+24,816
| +6% | +$139K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.